We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Ask ADVFN Intelligence (AI)
Q32 Bio Provides Bempikibart Program Update, Including Next Steps for Advancing Alopecia Areata Development Program PR Newswire WALTHAM, Mass., Dec. 10, 2024 -- SIGNAL-AA demonstrated encouraging...
Q32 Bio Reports Third Quarter 2024 Financial Results and Provides Corporate Update PR Newswire WALTHAM, Mass., Nov. 7, 2024 -- Bempikibart Phase 2 topline results in atopic dermatitis (AD) and...
Q32 Bio to Participate in Guggenheim's Inaugural Healthcare Innovation Conference PR Newswire WALTHAM, Mass., Nov. 5, 2024 WALTHAM, Mass., Nov. 5, 2024 /PRNewswire/ -- Q32 Bio Inc. (Nasdaq: QTTB...
| Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.1189 | -3.69254658385 | 3.22 | 3.39 | 2.99 | 215084 | 3.20103851 | CS |
| 4 | -0.0989 | -3.090625 | 3.2 | 4.1499 | 2.99 | 400049 | 3.45044878 | CS |
| 12 | -46.5689 | -93.7565935172 | 49.67 | 53.17 | 2.99 | 372548 | 9.53689136 | CS |
| 26 | -22.8989 | -88.0726923077 | 26 | 53.79 | 2.99 | 222205 | 18.06385011 | CS |
| 52 | -13.1389 | -80.9045566502 | 16.24 | 53.79 | 2.99 | 163541 | 18.68898979 | CS |
| 156 | -13.1389 | -80.9045566502 | 16.24 | 53.79 | 2.99 | 163541 | 18.68898979 | CS |
| 260 | -13.1389 | -80.9045566502 | 16.24 | 53.79 | 2.99 | 163541 | 18.68898979 | CS |
herbied47
3 weeks ago
Law of Averages
1 month ago
Contrarian Way
3 months ago
Monksdream
4 months ago
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
